10qs
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 13 ((3'r)-1'-{5-amino-1-[(2s)-1,1,1-trifluorobutan-2-yl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one)
3D- Structure doesn't exist.
